Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
05/2010
05/19/2010EP2185499A1 Method for producing amines from glycerin
05/18/2010US7718818 zirconium complexes of bis(o-hydroxybenzylamines); useful as intermediates for the preparation of fine chemicals, pharmaceuticals and plant protection products such as arthropodicidal oxadiazines
05/18/2010US7718802 Substituted melanocortin receptor-specific piperazine compounds
05/18/2010US7718704 Immunosuppressant compounds and compositions
05/18/2010US7718657 Certain indanyl urea modulators of the cardiac sarcomere
05/18/2010US7718656 Nitrooxyderivatives of prostaglandin amides, e.g., N-(3-(nitrooxy)propyl) 1R-[1 alpha (Z),2 beta (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenamide; reduced side effects,wider pharmacological activity, enhanced tolerability, long-acting hypotensive activity
05/18/2010US7718650 Piperazino or diazepino-substituted arylsulfonamides; obesity, type II diabetes and/or central nervous system disorders; 4-chloro-N-[5-(4-methyl-1,4-diazepan-1-yl)-2-nitrophenyl]benzenesulfonamide for example; Serotonin 5-HT6 receptor antagonist activity
05/14/2010WO2010054229A1 Quinoxaline-based lxr modulators
05/14/2010WO2010053757A1 2 -oxoquinoxalin blockers of the late sodium channel
05/14/2010WO2010053572A2 Aminoalcohol lipidoids and uses thereof
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010052448A2 Fused pyrazine derivatives as kinase inhibitors
05/14/2010CA2742954A1 Aminoalcohol lipidoids and uses thereof
05/14/2010CA2741537A1 Quinoxaline-based lxr modulators
05/13/2010US20100121064 Novel method for producing teta by means of eddn
05/13/2010US20100121057 Process for the Preparation of Piperazine Benzothiazoles
05/13/2010US20100120791 Cyclohexyl sulfonamide derivatives
05/13/2010US20100120790 Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating diabetes or obesity
05/13/2010US20100120785 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
05/13/2010US20100120778 Quinoxaline-based lxr modulators
05/13/2010US20100120775 Farnesoid X Receptor Agonists
05/13/2010US20100120769 Cyclohexyl piperazinyl methanone derivatives
05/12/2010EP2184278A1 P2x4 receptor antagonist
05/12/2010EP2183213A2 Optically active (r)-aryloxypropionic acid amides and herbicidal composition comprising same
05/12/2010EP2076499B1 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/12/2010CN101704797A compounds effecting glucokinase
05/12/2010CN101704792A Quinoxalinone derivative with matrix metalloproteinase inhibitory activity and preparation method and application thereof
05/12/2010CN101508679B Synthesis of D(-)-alpha-(4-ethyl-2,3-dioxygen ethylene imine-1-formamido) p-hydroxybenzene acetic acid
05/11/2010US7714012 Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010CA2462110C Phenyl-piperazine derivatives as serotonin reuptake inhibitors
05/11/2010CA2399089C Process for exchanging functional groups by halogen-metal exchange reaction
05/11/2010CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
05/06/2010WO2010050781A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010049302A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010US20100113782 Diacylglycerol Acyltransferase Inhibitors
05/06/2010US20100113781 Substituted heterocycle gamma-carbolines synthesis
05/06/2010US20100113462 Substituted benzoylamino-indan-2-carboxylic acids and related compounds
05/06/2010US20100113461 Substituted heterocyclic compounds
05/06/2010US20100113431 N-methyl piperazine modulators of h1 receptor
05/06/2010US20100113417 Substituted Spiroamine Compounds
05/06/2010US20100109514 Heterocyclic bridged biphenyls
05/06/2010DE102008053024A1 New nitrogen containing aromatic compounds are olfactory receptor inhibitors useful to combat insects, such as mosquitoes, mites and harmful arthropods such as ticks, and as a repellent
05/06/2010CA2741153A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/05/2010CN1871219B Hexylcarboxanilide
05/05/2010CN101702907A Piperazine compounds with a herbicidal action
05/05/2010CN101701011A Pyrazine derivatives, methods of use, and methods for preparing same
05/04/2010USRE41315 Modulators of dopamine neurotransmission
05/04/2010US7709639 Catalysis of diketopiperazine synthesis
05/04/2010US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/04/2010US7709484 1-((2R,5S)-5-Benzyl-2-naphthalen-2-ylmethyl-piperazin-1-yl)-3-(2,4-dichloro-phenyl)-propan-1-one; melanocortin receptor-associated disorder such as cachexia, obesity, erectile dysfunction or female sexual dysfunction
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010US7709467 Apoptosis promoters
05/04/2010US7708907 Liquid crystal compounds and liquid crystal compositions comprising the same
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
05/04/2010CA2312087C Preparation comprising sterically hindered amines for the prevention and treatment of inflammation
04/2010
04/29/2010US20100105953 Human Adam-10 Inhibitors
04/29/2010US20100105908 Process For The Preparation Of Levocetirizine And Intermediates Thereof
04/29/2010US20100105906 Novel phenyl amide or pyridyl amide derivatives
04/29/2010US20100105902 Organometallic Complex, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Including the Organometallic Complex
04/29/2010US20100105899 Integrated Photoactive Small Molecules and Uses Thereof
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105699 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
04/29/2010US20100105698 Therapeutic Methods and Compounds
04/29/2010US20100105693 Modulators of Muscarinic Receptors
04/29/2010US20100105686 Phenylsulfamoyl benzamide derivatives as bradykinin antagonists
04/29/2010US20100105683 Compounds useful for inhibiting chk1
04/28/2010EP2178849A1 Integrated photoactive agents and uses thereof
04/28/2010EP2178837A2 Isophthalamide derivatives inhibiting beta-secretase activity
04/28/2010EP1836175B1 Fluorescent pyrazine derivatives and methods of using the same in assessing renal function
04/28/2010EP1590321B1 Aryl alkyl carbamate derivatives production and use thereof in therapy
04/28/2010CN1854137B Method for resoluting zopiclone
04/28/2010CN1747929B Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
04/28/2010CN101698664A Preparation method of pharmaceutical intermediate 2-amine methylpyrazine hydrochloride
04/27/2010US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils
04/27/2010US7705007 Cis-imidazolines
04/27/2010US7705003 trans-N-{4-[2-[4-(indan-4-yl)-piperazin-1-yl]-ethyl]-cyclohexyl}-acetamidethe; highest affinity to D3 receptor; no disadvantages of each individual receptor action; antidepressant, anxiolitic agent, cognition activator; psychoses, schizophrenia, drug (alcohol, cocaine and nicotine) abuse, hyperactivity
04/27/2010US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase
04/27/2010US7704995 Protein kinase modulators and methods of use
04/27/2010US7704957 For therapy of AIDS
04/27/2010CA2493667C Vanilloid receptor ligands and their use in treatments
04/27/2010CA2437524C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/27/2010CA2408649C Piperazinedione compounds
04/22/2010WO2010044054A1 Phenethylamide derivatives and their heterocyclic analogues
04/22/2010WO2010043558A1 Production and use of methionyl-methionine as a feed additive for fish and crustaceans
04/22/2010WO2010043000A1 S1p receptors modulators and their use thereof
04/22/2010US20100099872 Production method for ethyleneamine mixtures
04/22/2010US20100099688 Novel phosphodiesterase inhibitors
04/22/2010US20100099684 Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
04/22/2010US20100099682 Acetylene derivatives
04/22/2010US20100099676 Sulfonylurea derivative capable of selectively inhibiting mmp-13
04/22/2010US20100099671 Glucokinase activator
04/22/2010US20100098661 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
04/22/2010US20100098630 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides
04/22/2010CA2740663A1 Production and use of methionylmethionine as feed additive for fish and crustaceans
04/22/2010CA2740484A1 S1p receptors modulators and their use thereof
04/22/2010CA2739344A1 Phenethylamide derivatives and their heterocyclic analogues
04/20/2010US7700624 To treat inflammatory diseases, immune diseases and cancer; 4-{[(1R3S)-3-isopropyl-3-({4-[4-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}carbonyl)cyclopentyl]amino}-1-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexanol; side effect reduction; improved long term safety profile; oral administration; half life
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 187